Search for: "Anda Pharmaceuticals, Inc" Results 1 - 20 of 605
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Endo Pharmaceuticals Inc. v. Actavis, Inc. & Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc. (Fed. Cir. 2014)
8 Apr 2014, 9:59 pm by Patent Docs
Actavis, Inc. and Endo Pharmaceuticals Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Sunovion Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2013)
26 Sep 2013, 9:33 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Par Pharmaceutical, Inc. v. Eagle Pharmaceuticals, Inc. (Fed. Cir. 2022)
21 Aug 2022, 9:11 pm by Patent Docs
Eagle Pharmaceuticals, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2023)
11 Jun 2023, 8:17 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Par Pharmaceutical, Inc. v. TWi Pharmaceuticals, Inc. (Fed. Cir. 2014)
3 Dec 2014, 9:59 pm by Patent Docs
TWI Pharmaceuticals, Inc., where the patentee prevailed only to face almost certain defeat on remand. [read post]
Patent Docs - http://www.patentdocs.org/
Par Pharmaceutical, Inc. v. Hospira, Inc. (Fed. Cir. 2020)
29 Nov 2020, 9:59 pm by Patent Docs
This truism was the basis for the Federal Circuit affirming the District Court's decision against a generic drug producer in its recent decision in Par Pharmaceutical, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Millennium Pharmaceuticals, Inc. v. Sandoz Inc. (Fed. Cir. 2017)
18 Jul 2017, 9:58 pm by Patent Docs
Noonan -- In multiple ANDA litigations against multiple defendants, Millennium Pharmaceuticals, Inc. had several of its asserted claims held invalid for obviousness at the district court. [read post]
Patent Docs - http://www.patentdocs.org/
Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc. (Fed. Cir. 2017)
8 May 2017, 8:27 pm by Patent Docs
Breckenridge Pharmaceutical, Inc., illustrates the risks a litigant can take when agreeing to stipulation in an effort at least to reduce litigation costs and issues presented at trial. [read post]
Patent Docs - http://www.patentdocs.org/
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2020)
3 Sep 2020, 9:23 pm by Patent Docs
Hikma Pharmaceuticals USA Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. (Fed. Cir. 2024)
24 Apr 2024, 9:27 pm by Patent Docs
Norwich Pharmaceuticals Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Bracco Diagnostics Inc. v. Maia Pharmaceuticals, Inc. (Fed. Cir. 2020)
21 Dec 2020, 9:03 pm by Patent Docs
Maia Pharmaceuticals, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Endo Pharmaceuticals Inc. v. Actavis LLC (Fed. Cir 2019)
6 May 2019, 9:58 pm by Patent Docs
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc. (Fed. Cir. 2021)
23 Dec 2021, 8:48 pm by Patent Docs
The case arose incident to ANDA litigation between the parties involving Corcept's Korlym product comprising the active pharmaceutical ingredient mifepristone for treating Cushing's Syndrome. [read post]
Patent Docs - http://www.patentdocs.org/
Nalproprion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc. (Fed. Cir. 2019)
20 Aug 2019, 9:59 pm by Patent Docs
Noonan -- Last week, the Federal Circuit reversed findings of non-obviousness and affirmed (over Chief Judge Prost's dissent) a finding that claims asserted in ANDA litigation were not invalid for failure to satisfy the written description requirement in Nalproprion Pharmaceuticals, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Rockville biopharm CASI acquires ANDA portfolio from Sandoz
29 Jan 2018, 12:51 pm by Daily Record Staff
Rockville-based CASI Pharmaceuticals Inc., a biopharmaceutical company dedicated to bringing quality pharmaceutical products to the Chinese and U.S. markets, announced Monday it has acquired a portfolio of 25 U.S. [read post]
On the Record - http://thedailyrecord.com/ontherecord/
Teva Pharmaceuticals USA, Inc. v. Eisai Co., Ltd. (Fed. Cir. 2010)
12 Oct 2010, 9:59 pm by Patent Docs
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Valeant Pharmaceuticals Int'l v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2020)
8 Apr 2020, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Biotechnology Patent Attorney Files Lawsuit Against Pharmaceutical Cos. For Watson Laboritories Under 21 U.S.C. § 355 For ANDA Filed With FDA
20 Mar 2008, 1:55 am
Duramed Pharmaceuticals, Inc., SACV08-0243 JVS (C.D. [read post]
Los Angeles Intellectual Property Trademark Attorney Blog - http://www.iptrademarkattorney.com/
Celgene Corp. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2021)
9 Nov 2021, 9:31 pm by Patent Docs
Mylan Pharmaceuticals Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Senju Pharmaceutical Co. v. Apotex Inc. (Fed. Cir. 2014)
7 Apr 2014, 9:59 pm by Patent Docs
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Apotex in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug Gatifloxacin as claimed in U.S. [read post]
Patent Docs - http://www.patentdocs.org/